Financhill
Back

RenovoRx Stock Predictions

RenovoRx Stock Forecast

  • Is RenovoRx Stock Undervalued?
    The current RenovoRx [RNXT] share price is $1.27. The Score for RNXT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • RNXT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will RenovoRx Stock Go Up Next Year?

Data Unavailable

RenovoRx Stock Rating

Data Unavailable

RenovoRx Stock Price History

Is RNXT stock going to rise?

  • The current trend is moderately bullish and RNXT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
renovorx.com

52-Week Data

52-Week High:
1.69
52-Week Low:
0.75

Prediction Charts

Market Cap:
46.4M
Price in USD:
1.27
Volume:
51.4K
Beta:
1.29

Technical Analysis

SMA50:
1.31
SMA100:
1.14
SMA200:
1.16
52-Wk Change:
3.25%

Stock Predictions

  • Is RenovoRx stock public?
    Yes, RenovoRx is a publicly traded company.
  • What is the RenovoRx stock quote today?
    The RenovoRx stock price is 1.27 USD today.
  • How to buy RenovoRx stock online?
    You can buy RenovoRx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-8 1.34 1.30 1.34 1.30
Jul-9 1.30 1.32 1.35 1.29
Jul-10 1.30 1.34 1.37 1.30
Jul-11 1.30 1.29 1.37 1.28
Jul-14 1.29 1.40 1.40 1.29
Jul-15 1.38 1.32 1.39 1.30
Jul-16 1.32 1.30 1.33 1.27
Jul-17 1.32 1.30 1.32 1.28
Jul-18 1.33 1.30 1.35 1.28
Jul-21 1.31 1.29 1.31 1.26
Jul-22 1.28 1.28 1.30 1.23
Jul-23 1.27 1.27 1.28 1.24
Jul-24 1.30 1.30 1.30 1.26
Jul-25 1.30 1.27 1.30 1.27

RenovoRx Earnings

Data Unavailable

RenovoRx Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.02 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.

* RenovoRx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.